Diosmectite (Smecta®)

DRUG3 trials

Sponsors

Ipsen, Ipsen Pharma SAS

Conditions

Chronic Functional Diarrhea of Unknown OriginDiarrheachronische diarree. chronic diarrhea

Phase 1

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

CompletedNCT03045926

IpsenChronic Functional Diarrhea of Unknown Origin

Start: 2016-08-31End: 2017-05-09Updated: 2019-04-05

Phase 4

Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults

CompletedNCT00276328

Start: 2005-01-31End: 2006-07-31Updated: 2020-04-28

Unknown Phase

Assessment of elemental impurities level after chronic administration of Diosmectite (SMECTA®) in subjects with chronic diarrhoea.

Active, not recruitingNL-OMON43250

Ipsen Pharma SASchronische diarree. chronic diarrhea

Start: 2016-09-01Target: 35Updated: 2024-02-28

Related Papers

Long-term diosmectite use does not alter the gut microbiota in adults with chronic diarrhea

BMC Microbiology2022-02-123 citations